Author:
Ren Chenyu,Li Yixuan,Du Peipei,Zhang Xuebin,Xue Wanjun,Zhang Chi
Abstract
Abstract
Background
Medical research in complementary and alternative medicine (CAM) has increased recently, raising ethical concerns about the moral status of CAM. Medical academic journals are responsible for conducting ethical review (ER) of manuscripts to protect the interests of human subjects and to make ethical results available before deciding to publish. However, there has been no systematic analysis of the ER in CAM journals. This study is aim to evaluate the current status of ethical requirements and compliance in CAM journals.
Methods
This is a cross-sectional study. We reviewed instructions for authors (IFAs) of CAM journals included in the Journal Citation Reports (2021) (https://jcr.clarivate.com) for general information and requirements for ER. We also browsed the manuscripts regarding randomized controlled trials published by CAM journals in Q1 and Q2 section from January to June, 2023, to check the actual situation of ethical requirement. Descriptive statistics and Fisher’s exact test were used for statistical analysis.
Results
27 journals and 68 manuscripts were ultimately included. 92.6% (25/27) IFAs included keywords of ER, indicating the presence of ethical considerations. However, no specific ER was required for CAM (n = 0). We categorized journals by Geographic origin, JCR section, Year of electronic JCR, Types of studies, % of OA Gold to explore the factors that could influence CAM journals to have certain ethical review policies. The results showed there was no statistical significance in certain ethical review policy in any classification of journals (p > 0.05). All RCT manuscripts included in the study generally met the requirements of the published journals for ethical review.
Conclusions
All IFAs discussed ER, but the content was scattered, unfocused, and there were no specific ER requirements regarding CAM. Although the manuscripts basically met the requirements of the journal, it was not possible to get closer to the process of ER in the manuscript. To ensure full implementation of these policies in the future, CAM journals should require authors to provide more details, or to form a list of items necessary for CAM ethical review.
Funder
Leading Talents Project of Dongzhimen Hospital
Beijing University of Chinese Medicine Project
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. U.S. Food and Drug Administration. 2015–2019 Drug Trials Snapshots Summary Report.[EB/OL].(2019)[2023-05-29]. https://www.fda.gov/media/143592/download?utm_medium=email&utm_source=govdelivery
2. World Health Organization. Number of clinical trials by year, country, WHO region and income group., (1999–2022).[EB /OL].(2023-02)[2023-05-29]. https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/number-of-clinical-trials-by-year-country-who-region-and-income-group
3. ClinicalTrials.gov Website. U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/home. Accessed May 29, 2023.
4. Nuremberg Military Tribunal. Nuremberg Code[J] JAMA. 1996;276(20):1691.
5. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects[J]. JAMA. 1997;277(11):925–6.